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Abstract Stresses that impair the function of the endoplasmic
reticulum (ER) lead to an accumulation of unfolded protein in
the ER. Under these conditions, the expression of a variety of
genes involved in preventing the accumulation of the unfolded
proteins is induced. Yeast Hrd1p is an ER stress-inducible ER
membrane protein that acts as a ubiquitin ligase (E3) with a
RING ¢nger motif and plays a role in the ubiquitination of
proteins in the ER. We report here the identi¢cation and char-
acterization of a human homolog to yeast Hrd1p. The predicted
structures are highly conserved from yeast to humans. Indeed,
human HRD1 was localized to the ER and ubiquitinated its
substrates. Furthermore, it was found that human HRD1 was
up-regulated by ER stress via IRE1 and ATF6, which are ER
stress transducers. Interestingly, 293 cells stably expressing
wild-type HRD1, but not the C329S mutant, a¡orded resistance
to ER stress-induced apoptosis. These results suggest that the
production of HRD1 is up-regulated to protect against ER
stress-induced apoptosis by degrading unfolded proteins accu-
mulated in the ER.
4 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
The exposure of cells to various forms of stress interfering
with the functions of the endoplasmic reticulum (ER) leads to
the accumulation of unfolded protein in the ER lumen. Under
these conditions, known as ER stress, a signal transduction
pathway, called the unfolded protein response (UPR), is acti-
vated to increase the expression of ER stress response genes,
such as chaperone protein genes [1].
The UPR has been well de¢ned in Saccharomyces cerevisiae
[2]. When unfolded proteins accumulate in the ER lumen,
Ire1p, which is a protein kinase and ribonuclease in the ER
membrane, senses them and activates itself by trans-autophos-
phorylation, and eventually induces the gene expression. A
recent microarray analysis in yeast has shown that the expres-
sion of a variety of genes is induced via Ire1p in response to
ER stress [3]. This result revealed that UPR-regulated genes
consist of another group involved in ER-associated degrada-
tion (ERAD), including HRD1/DER3, HRD3, DER1 and
UBC7. The proteins encoded by these genes serve to remove
unfolded proteins by retrograde transport from the ER back
to the cytosol and subsequent degradation using the ubiqui-
tin-proteasome system [4^6]. Hrd1p is a ubiquitin ligase (E3)
in the ER membrane with its N-terminal hydrophobic region
in multiple transmembrane spans, and with a C-terminal hy-
drophilic region containing a RING-H2 motif required for
binding to ubiquitin-conjugating enzyme (E2). Hrd1p partic-
ipates in the degradation of Hmg2p, a homolog of mamma-
lian hydroxymethylglutaryl-coenzyme A reductase [7^9].
Two Ire1p homologs (K and L) exist in mammalian cells
and serve as activators of the UPR [10,11]. In addition, ATF6
has been characterized as another UPR inducer, which is pro-
cessed and liberated from the ER membrane in response to
ER stress, and subsequently translocates from the ER mem-
brane to the nucleus as a transcription factor [12,13].
Although many more genes related to the UPR should exist
in mammals than yeast, little is known as yet, especially of the
mammalian ERAD system.
Interestingly, it was recently suggested that neuronal cells in
neurodegenerative diseases undergo apoptosis induced by ER
stress, due to the accumulation of unfolded proteins in the ER
with the collapse of the UPR system [14^17]. Therefore, it is
necessary to identify novel mammalian molecules induced by
the UPR and elucidate the contribution to the prevention of
ER stress-induced apoptosis. We report here that a human
homolog of Hrd1p was identi¢ed and characterized as a ubiq-
uitin ligase, and that its expression was induced by the UPR
to protect cells from ER stress through ERAD.
2. Materials and methods
2.1. Cloning and expression vector construction
Human HRD1 was cloned from HEK293 cDNA using KIAA1810-
speci¢c primers. Ampli¢ed HRD1 cDNA was ligated into the vector
pcDNA6/Myc-His (Invitrogen), expressing Myc (c-Myc) and polyhis-
tidine (6UHis) epitopes at the C-terminus of the inserted sequence.
IRE1 and ATF6 (a truncated form encoding the cytoplasm region
corresponding to amino acids 1^373) were ampli¢ed with a hemag-
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glutinin epitope at the C-terminus or N-terminus, respectively, and
then cloned into the mammalian expression vector pCR3.1 (Invitro-
gen). The HRD1-C329S and IRE1-K599A mutants were constructed
by PCR using the overlapping method.
2.2. Cell culture
Human embryonic kidney (HEK) 293T cells were maintained in
Dulbecco’s modi¢ed Eagle’s medium supplemented with 10% (v/v)
heat-inactivated fetal calf serum, 100 U/ml of penicillin, and 100 Wg/
Fig. 1. Amino acid sequence, subcellular localization and tissue distribution of human HRD1. A: Amino acid sequence alignment of Hrd1p ho-
mologs. H.s. (Homo sapiens) is human HRD1. M.m. (Mus musculus), D.m. (Drosophila melanogaster) and C.e. (Caenorhabditis elegans) are pu-
tative proteins, which are similar to yeast Hrd1p (S.c. : S. cerevisiae) in the databases. Identical sequences with Hrd1p are shown in red. Pre-
dicted transmembrane regions are underlined. The RING ¢nger domain is boxed, and its conserved motif is green. An asterisk indicates the
site of a point mutation. B: Subcellular localization of HRD1. HRD1 tagged with a Myc epitope at its C-terminus was transiently overex-
pressed in CCF-STTG1 cells. Myc-HRD1 and endogenously expressed PERK were detected by immuno£uorescence microscopy using anti-Myc
(left panel) and anti-PERK (center panel) antibodies, respectively. The right panel is the merged image of the left and center panels. C: Tissue
distribution of HRD1 in humans. A human multiple tissue Northern1 blot (2 Wg of poly(A)þ RNA/lane, Clontech) was hybridized with a 32P-
labeled HRD1 cDNA probe. Positions of standard RNA markers are shown on the left with their size.
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ml of streptomycin at 37‡C in a humidi¢ed 5% CO2/95% air atmo-
sphere. Human astrocytoma CCF-STTG1 cells were maintained in
RPMI medium. 293 cell lines stably expressing HRD1s were gener-
ated by transfection with wild-type (wt) or mutated (C329S) HRD1-
pcDNA6, and then selected in medium containing 5 Wg/ml of blasti-
cidin (Invitrogen).
2.3. Immunohistochemistry
To detect the expression of HRD1 at the cell level, CCF-STTG1
cells were transfected with the expression vector wt HRD1 using the
LipofectAMINE 2000 reagent, ¢xed with 1% paraformaldehyde phos-
phate bu¡er for 5 min, and permeabilized with 0.5% Triton X-100 for
5 min. The cells were then stained for the presence of proteins with
ant-Myc (9E10, Oncogene) and anti-PERK (Santa Cruz) antibodies.
2.4. Immunoprecipitation and immunoblotting
293 cells were transfected with wt or C329S HRD1 expression vec-
tors and treated with 5 WM MG132 (Peptide Institute, Japan) for
various periods before being harvested. The cells were lysed in lysis
bu¡er (10 mM Tris^HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA, 10%
glycerol and 0.5% Triton X-100) with complete protease inhibitors
(Roche Diagnostics, Germany) at 4‡C for 20 min, and then lysates
were centrifuged. The supernatant was immunoprecipitated using
anti-Myc antibody and protein G-Sepharose (Amersham Pharmacia
Biotech, UK). The whole cell lysates were subjected to Western blot
analysis using anti-multiubiquitin (FK2, Nippon Bio Test Laboratory,
Japan) or anti-Myc antibodies. Subsequently, the bands were detected
using Ig-horseradish peroxidase-conjugated antibody and the en-
hanced chemiluminescence (ECL) detection system (Amersham Phar-
macia Biotech, UK).
2.5. Cell death assay
The apoptotic cells were detected with cytoplasmic histone-associ-
ated DNA fragments generated by endonuclease cleavage using the
Cell Death Detection ELISA (Roche Diagnostics, Germany) accord-
ing to the manufacturer’s protocol. The results are expressed as the
fold increase in optical density, resulting from the activity of peroxi-
dase-conjugated anti-DNA antibody complexed with cytoplasmic nu-
cleosomes of treated cells, compared with the control.
3. Results
3.1. Identi¢cation of human HRD1
To identify the human homolog of yeast Hrd1p, we
searched the protein databases (GenBank CDS translations,
PDB, SwissProt, PIR and PRF) with NCBI BLAST using the
yeast Hrd1p amino acid sequence. An already isolated human
clone, KIAA1810 (GenBank accession number AB058713),
the function of which is unknown, was discovered as a can-
didate for the human homolog of Hrd1p. We decided to study
this clone, termed HRD1. The human HRD1 protein has
26.2% overall identity to yeast Hrd1p in amino acid sequence,
the RING ¢nger domain showing 45.1% identity. Moreover,
we searched for other Hrd1p homologs in a number of spe-
cies, and found that the N-terminal half of the protein is
comparatively well conserved in the predicted six transmem-
brane domains and the RING ¢nger domain between species
compared to the C-terminal side (Fig. 1A). Next, to examine
the subcellular localization of human HRD1 protein, Myc-
tagged HRD1 was overexpressed in CCF-STTG1 cells. The
HRD1 protein co-localized with endogenous PERK, an ER
stress sensor protein in the ER membrane (Fig. 1B), indicating
that localization of human HRD1 is conserved between yeast
and humans. Moreover, the distribution of HRD1 in human
organs was examined by Northern blot analysis using a hu-
man HRD1-speci¢c probe. Human HRD1 was ubiquitously
expressed in all organs and detected as a single species of 4.2
kb. In particular, the HRD1 mRNA was abundant in pan-
creas, liver and skeletal muscle (Fig. 1C).
3.2. HRD1 has ubiquitin ligase activity
Yeast Hrd1p acts as a ubiquitin ligase in the ERAD system.
To elucidate whether the function of HRD1 is conserved in
humans, we investigated the E3 activity of human HRD1. We
performed an immunoprecipitation assay using Myc-HRD1
overexpressed in 293 cells, followed by Western blotting
with anti-multiubiquitin monoclonal antibody. The co-immu-
noprecipitates with Myc-HRD1 were detected as slowly mi-
grating bands by an anti-multiubiquitin antibody, and the
intensity of this band was strengthened on the addition of
MG-132, a proteasome inhibitor, in a time-dependent manner
(Fig. 2, upper panel). These high molecular weight smear
bands seem to involve unidenti¢ed substrates ubiquitinated
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Fig. 2. HRD1 has an E3 ubiquitin ligase activity. 293 cells were transfected with empty vector plasmid, Myc-tagged wt or C329S HRD1
cDNA, and treated with 5 WM MG-132 for the periods indicated. At 48 h after transfection, whole cell lysate was extracted, immunoprecipi-
tated with anti-Myc monoclonal antibody (9E10), and Western blotted with anti-multiubiquitin monoclonal antibody (FK2) (upper panel) or
anti-Myc monoclonal antibody (lower panel).
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and co-immunoprecipitated by HRD1, since the form of auto-
ubiquitinated HRD1 detected by the anti-Myc antibody was
di¡erent from that of substrates detected by the anti-multi-
ubiquitin antibody (data not shown). In yeast Hrd1p, a cys-
teine at 399 in the RING ¢nger domain is necessary for the
E3 activity, since the mutated Hrd1p C399S fails to bind the
E2 proteins and ubiquitinate its substrates [9,18]. A human
HRD1 mutant defective in E3 activity was constructed in
which the conserved Cys-329 corresponding to yeast Cys-
399 was replaced with serine, on the basis of the complete
conservation of the consensus sequence in the RING ¢nger
motif of HRD1 (Fig. 1A). C329S HRD1 was transfected into
293 cells, and the cells subsequently immunoprecipitated
with an anti-Myc antibody. As expected, multiubiquitinated
proteins were not observed in mutated HRD1-expressing
cells (Fig. 2, upper panel). These results indicate that
human HRD1 has E3 activity and can ubiquitinate its sub-
strates.
3.3. HRD1 expression is induced by ER stress
In yeast, the expression of a number of genes related to
ERAD is up-regulated by the UPR [2]. Next, to elucidate
whether the induction mechanism for HRD1 is conserved in
mammals, we examined the expression of mRNA under ER
stress using 293 cells. Cells were treated with an ER stress-
inducing reagent, such as thapsigargin (sarco/endoplasmic re-
ticulum Ca2þ ATPase inhibitor), tunicamycin (N-glycosyla-
tion inhibitor), brefeldin A (ER^Golgi transport inhibitor)
or dithiothreitol (DTT; reducing agent), and mRNA levels
of HRD1 were then measured by reverse transcription-poly-
merase chain reaction (RT-PCR). A marked increase was ob-
served in the HRD1 mRNA levels in response to these ER
stresses (Fig. 3A,B), although other forms of stress, including
heat shock, produced little change (Fig. 3B). Moreover,
CHOP and Parkin, known as ER stress response gene prod-
ucts [19,20], were concomitantly produced in response to these
reagents (Fig. 3A). In contrast, HSP70, a cytosolic stress re-
sponse gene product, exhibited no increase at the mRNA level
(Fig. 3B). In yeast, Ire1p mediates the expression of HRD1
and other ER stress-induced genes in response to ER stress
[2]. On the other hand, in mammals, in addition to IRE1s (K
and L), ATF6 participates in the induction of ER stress re-
sponse genes [21^23]. We next investigated whether overex-
pression of IRE1 and ATF6 can up-regulate the production
of human HRD1, as that of Ire1p induces an increase in yeast
HRD1. Overexpression of IRE1K and ATF6 (1^373; cytoplas-
mic domain worked as a transcription factor) produced an
increase in mRNA of human HRD1 (Fig. 3C). Furthermore,
we examined the dominant negative e¡ect of the IRE1-K599A
mutant, in which the ATP binding site at lysine residue 599,
required for the kinase activity, was replaced with alanine, on
the expression of HRD1 induced by ER stress. The level of
HRD1 mRNA expression induced by tunicamycin was atte-
nuated in 293 cells stably expressing the IRE1-K599A mutant,
compared with normal 293 cells (Fig. 3D). On the other hand,
the ER stress-induced CHOP expression was also partially
reduced by expression of IRE1-K599A (Fig. 3D), indicating
that this mutant could e¡ectively inhibit the UPR pathway.
These results indicate that the mechanism by which UPR in-
duces expression of HRD1 is conserved from yeast to mam-
mals in the pathway via IRE1. In addition, ATF6 is also
capable of inducing HRD1 expression.
3.4. HRD1 suppresses ER stress-induced apoptosis
It has been reported that Parkin, an E3 ubiquitin ligase
involved in ERAD, is up-regulated by the UPR and protects
cells from ER stress-induced apoptosis by accelerating the
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Fig. 3. HRD1 is up-regulated by the unfolded protein response. A:
Time-dependent induction by ER stress in HRD and other ER
stress response genes. 293 cells were treated with thapsigargin (TG;
1 WM) for the periods indicated, then total RNA was prepared and
subjected to RT-PCR using speci¢c primers (HRD1, CHOP, Parkin,
GAPDH). B: The induction of HRD1 by various forms of stress.
293 cells were treated with tunicamycin (TM; 2 Wg/ml), brefeldin A
(BFA; 1 Wg/ml), DTT (2 mM) or heat shock (HS; 42‡C, 1 h) for 6 h.
C: E¡ect of overexpressing IRE1 and ATF6 on the expression of
HRD1. 293 cells were transfected with IRE1 or ATF6 (N-terminal
side in the cytosol acting as a transcription factor) using Lipofect-
AMINE 2000. D: E¡ect of dominant negative IRE1-K599A mutant
on ER stress-induced HRD1 expression. Normal 293 cells and those
stably expressing IRE1-K599A were treated with 2 Wg/ml of tunica-
mycin for the periods indicated.
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degradation of unfolded proteins accumulated in the ER lu-
men [16,20]. Therefore, up-regulation of HRD1 expression
might rescue cells from ER stress-induced apoptosis, if
HRD1 serves as an E3 to degrade the unfolded protein in
the ER. To investigate whether HRD1 suppresses ER stress-
induced apoptosis, we performed a apoptosis assay using 293
cells stably expressing human HRD1s. Wt HRD1-expressing
cells were signi¢cantly more resistant to ER stress, including
thapsigargin and tunicamycin, than normal 293 cells. In con-
trast, the C329S HRD1 mutant-expressing cells, lacking E3
activity, showed no resistance to ER stress-induced apoptosis
compared with normal 293 cells (Fig. 4). On the other hand,
no di¡erence among wt, mutant HRD1-transfected and un-
transfected cells was observed in the apoptosis induced by
staurosporine (Fig. 4B). These results indicate that the pro-
tective e¡ect of HRD1 against apoptosis is dependent on its
E3 activity and speci¢c to ER stress.
4. Discussion
We have identi¢ed a human homolog of Hrd1p by homol-
ogy search and using prediction programs for localization and
domains, and demonstrated that human HRD1 has functional
homology to yeast Hrd1p. Moreover, we have shown that its
expression is induced by ER stress, resulting in protection
against ER stress-induced apoptosis through the ubiquitin-
proteasome system.
There is further evidence that human HRD1 is a bona ¢de
homolog of yeast Hrd1p. Hrd3p, another UPR-inducible
ERAD protein, interacts with Hrd1p and mediates the regu-
lation of Hrd1p stability and activity [7]. HRD1 can interact
with suppressor/enhancer of lin-12 (SEL1L), which is a can-
didate homolog of Hrd3p (data not shown). Although SEL1L
has been cloned as a human homolog of Caenorhabditis ele-
gans sel-1, little is known about its function in relation to
ERAD [24]. We have identi¢ed SEL1L by the same strategy,
and found that it too is induced by the UPR (data not
shown). Therefore, these results give us con¢dence that
HRD1 is a homolog of Hrd1p.
Parkin, another cytosolic E3 protein involved in mamma-
lian ERAD, has two RING ¢nger domains and a ubiquitin-
like (UBL) domain that interacts with 26S proteasome. How-
ever, HRD1 has only a RING ¢nger domain, no UBL do-
main, indicating that HRD1 may require the cooperation of
another UBL protein for proteasomal degradation. On the
other hand, Kokame et al. and we have identi¢ed ER
stress-inducible proteins, Herp and ubiquilin, respectively
[25,26]. Both have a UBL domain and exist in the ER as
transmembrane protein. These reports suggest that HRD1
and UBL proteins, including Herp and ubiquilin, could coop-
erate in ubiquitination and interaction between the substrates
and 26S proteasome.
Induction of human HRD1 expression is mediated by an
IRE1K-dependent pathway in response to ER stress. This is
consistent with results that the expression of yeast Hrd1p and
other ERAD-related genes is up-regulated by Ire1p [2]. This
suggests that the mechanism by which UPR induces expres-
sion of HRD1 is conserved from yeast to mammals. On the
other hand, the involvement of an ATF6-mediated pathway(s)
in the expression of ERAD genes, including HRD1, remains
unclear, since no ATF6 counterpart exists in yeast. Although
ER stress response genes have ATF6 binding elements, ERSE,
in the promoters, no ERSE motif exists in the putative HRD1
promoter [14]. Further study is necessary to elucidate the
mechanism by which ATF6 induces the expression of mam-
malian genes, particularly in ERAD.
Northern blot analysis revealed that HRD1 is expressed at
a high level in pancreas. Moreover, expression of SEL1L is
also abundant in the tissue [24]. It was reported that IRE1K is
expressed predominantly in pancreas [10]. These results sug-
gest that the ERAD system is essential for the function of ER-
developed tissues, including the pancreas, and that IRE1K
plays a key role in the regulation of ERAD-related gene ex-
pression in those tissues.
HRD1 has a protective e¡ect dependent on the E3 activity
against ER stress. This ¢nding suggests that ERAD proteins
induced by ER stress play a critical role in preventing ER
stress-induced apoptosis. In fact, overexpression of Parkin
can suppress apoptosis induced by ER stress through the E3
activity [20]. In this study, we also demonstrated the protec-
tive e¡ect of overexpression of HRD1 against ER stress-in-
duced apoptosis. These results suggest that HRD1, Parkin
and other unidenti¢ed ubiquitin ligases involved in ERAD
are concomitantly up-regulated in response to ER stress via
the UPR signaling pathways, resulting in suppression of ap-
optosis through degradation of unfolded proteins by those
components.
Furthermore, the ERAD action seems to have a great in-
£uence on the accumulation of proteins in neurons. For ex-
ample, the mutations in the presenilin-1 (PS1) gene that cause
early onset familial Alzheimer’s disease (FAD) attenuate the
UPR by disturbing the activation of IRE1 and ATF6, increas-
ing the vulnerability to ER stress by altering the expression of
the ER chaperone [14,15]. These reports and our ¢ndings
suggested that mutations in PS1 attenuate the expression of
IRE1 and ATF6-dependent genes related to ERAD, including
HRD1 and SEL1L, resulting in an accumulation of unfolded
proteins in the ER, and cause FAD. Therefore, studying the
induction mechanism of ERAD genes and protective e¡ect
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Fig. 4. HRD1 rescues the cells from ER stress-induced apoptosis.
Normal, wild-type (WT) or mutant (C329S) HRD1-expressing 293
cells were treated with thapsigargin (1 WM), tunicamycin (10 Wg/ml),
and staurosporine (0.5 WM). Forty-eight hours after incubation, the
apoptotic cells were detected by ELISA of cytoplasmic nucleosomes,
as described in Section 2. Values represent the meansSS.E.M. of
three independent experiments. Asterisks represent signi¢cantly dif-
ferent values of wt HRD1-expressing cells from those of normal 293
cells (*P6 0.05; **P6 0.01; Student’s t-test).
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against ER stress in mammals may provide a clue to the
mechanism behind neurodegenerative diseases.
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